title: Commentary.
authors: John F
authors: JF
authors: Rothrock
mesh_terms: D002986:Clinical Trials as Topic; D004087:Dihydroergotamine / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D058825:Serotonin 5-HT1 Receptor Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics; D018170:Sumatriptan / Q000008:administration & dosage / Q000493:pharmacokinetics*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D058825:Serotonin 5-HT1 Receptor Agonists; D014662:Vasoconstrictor Agents; D004087:Dihydroergotamine; D018170:Sumatriptan